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SUMMARY – Among many disease states as known initiators of acute respiratory distress syn-
drome (ARDS), diabetic ketoacidosis (DKA) is the rarest one. We present a 4-year-old boy with 
DKA as the fi rst manifestation of insulin-dependent diabetes mellitus who developed ARDS, re-
quired tracheal intubation and mechanical ventilation, and survived without signifi cant sequels. To 
improve survival of patients with ARDS as a complication of DKA, physicians should be aware of this 
rare pulmonary complication and its appropriate management.
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Introduction
Acute respiratory distress syndrome (ARDS) is an 
acute diff use infl ammatory lung injury characterized 
clinically by sudden onset of dyspnea, progressive hy-
poxemia and decreased lung compliance accompanied 
by the development of diff use infi ltrates on chest x-
ray1. Th e pathogenesis of ARDS involves an infl am-
matory process at the alveolar-capillary interface lead-
ing to the accumulation of protein-rich fl uid in the 
alveolar space1. Many causes of acute direct and indi-
rect lung injury have been described as possible initia-
tors of ARDS2. According to literature data, ARDS 
could be a rare complication associated with the acute 
onset of diabetic ketoacidosis (DKA), occurring usu-
ally in adolescents and young adults3-6.
Herein we report a case of ARDS in a previously 
healthy 4-year-old boy admitted to the intensive care 
unit because of the initial episode of DKA as the fi rst 
manifestation of type 1 diabetes mellitus (DM).
Case Report
A 4-year-old boy with unremarkable medical and 
family history presented to the emergency room with 
a 2-day history of malaise, lethargy, tachypnea, sore 
throat, abdominal pain, vomiting and dehydration. In 
retrospect, the history revealed polyuria, polydipsia 
and a documented 4-kg weight loss in 3 weeks preced-
ing admission. He was afebrile, tachypneic (46 breaths 
per minute) with Kussmaul respirations, his heart rate 
was 156 beats per minute and blood pressure was 90/55 
mm Hg. Th e patient’s physical fi ndings included light 
drowsiness, no jugular distension, with diff use rhonchi 
in all lung areas.
Diabetic ketoacidosis was confi rmed (plasma glu-
cose level 29.8 mmol/L, pH 6.788, pO
2 
5.20 kPa, 
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pCO
2 
4.43 kPa, bicarbonate 4.7 mmol/L, sodium 135 
mmol/L, potassium 5.1 mmol/L). Urine analysis re-
vealed only glucosuria and ketonuria. Immediate treat-
ment consisted of insulin infusion, intravenous saline, 
potassium replacement and symptomatic respiratory 
treatment. Hypotension was controlled with volume 
expansion, vasopressors and inotropes. In spite of ther-
apy, the patient’s status continued to deteriorate and a 
few hours later he suddenly developed severe dyspnea, 
increased tachypnea, restlessness and cyanosis. Auscul-
tation of the chest disclosed diff use crackles and rhon-
chi in all lung areas. Hypoxemia was confi rmed and 
chest radiograph showed bilateral severe diff use infi l-
trates, but no cardiomegaly (Fig. 1). Acute respiratory 
failure secondary to ARDS was diagnosed. Th e patient 
was transferred to the intensive care unit and he was 
treated initially with oxygen by facemask. However, his 
condition deteriorated further and a few hours later 
endotracheal intubation and mechanical ventilation 
were required. Th roat culture was positive for group A 
beta-hemolytic streptococci, while cultures of urine 
and blood specimens were negative. Intravenous co-
amoxiclav was administered every 8 hours. Due to fur-
ther clinical deterioration, the patient was transferred 
to our hospital. On admission to our hospital, he was 
intubated, mechanically ventilated by transport venti-
lator (SIMV, FiO
2
 56%, arterial oxygen saturation 
95%, respiratory rate 25 breaths per minute), his heart 
rate was 136 beats per minute and blood pressure was 
113/75 mm Hg, afebrile, sedated and diff usely edema-
tous.
Th e main laboratory fi ndings on admission are pre-
sented in Table 1. Leukocyte count was 18.3, with dif-
ferential of 67 neutrophils, 25 lymphocytes, 7 mono-
cytes and 1 eosinophil. Prothrombin time, platelet 
count, troponin T level, liver function tests and levels 
of serum and urine amylase were within the normal 
limits. On urine analysis, only glucosuria was noted. 
Cultures of tracheal tube, urine and blood specimens 
were negative. Electrocardiography pattern was nor-
mal. Chest high-resolution computed tomography re-
vealed the following: bilateral areas of patchy abnor-
malities and mixed ground-glass appearance and con-
solidation, predominantly in the right middle and left 
upper lobes, but neither cardiomegaly nor mediastinal 
lymphadenopathy was found (Fig. 2A, B). Treatment 
with antibiotics was continued for 10 days. In the next 
4 days, subcutaneous injections of regular insulin re-
placed i.v. insulin to maintain euglycemia. During the 
next three days, his condition improved enough to be 
weaned from ventilator. He was euglycemic with no 
ketonuria and continued to receive subcutaneous regu-
lar insulin. He made good recovery over the next few 
Fig. 1. Chest x-ray demonstrating bilateral severe diff use 
infi ltrates consistent with acute respiratory distress 
syndrome.
Table 1. Th e main laboratory test results on patient 
admission to our hospital
 Result Reference value




C-reactive protein (mg/L) 43.1 <5
Leukocyte (x109/L) 18.3 6.0-16.0







 (kPa) 7.4 10.70-12.70
Bicarbonate (mmol/L) 21.2 21-26
Sodium (mmol/L) 135 134-143
Chloride (mmol/L) 102 96-109
Potassium (mmol/L) 4.5 3.5-6.0
Magnesium (mmol/L) 0.75 0.65-1.03
BUN (mmol/L) 5.4 1.8-6.0
Triglycerides (mmol/L) 1.98 <1.7
Cholesterol (mmol/L) 4.8 <4.7
HDL (mmol/L) 1.06 >1
LDL (mmol/L) 2.83 <3
BUN = blood urea nitrogen; HDL = high density lipoprotein; LDL 
= low density lipoprotein
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days, his blood gas levels improved steadily, and he was 
on room air after 7 days of hospital stay. All respiratory 
symptoms cleared and chest x-ray markedly improved 
(Fig. 3). Defi nitive diagnosis was ARDS in association 
with DKA as the fi rst manifestation of type 1 DM in 
a 4-year-old boy.
Discussion
Th e most common causes leading to ARDS are 
pneumonia, sepsis, aspiration of gastric contents, toxic 
inhalation, near drowning, and trauma. We report an 
unusual case of a child with DKA who developed 
ARDS, required tracheal intubation and mechanical 
ventilation, and survived without signifi cant sequels. 
Th e clinical disorders usually associated with ARDS 
were systematically excluded on the basis of the com-
plete workup and clinical course, supporting DKA as 
the probable initiating factor. DKA is a life-threaten-
ing condition that is characterized by hyperglycemia, 
metabolic acidosis, with associated glycosuria, ketonu-
ria and ketonemia as the result of absolute (in previ-
ously undiagnosed type 1 DM and when patients on 
treatment deliberately or inadvertently do not take in-
sulin) or relative insulin defi ciency (in cases when the 
concentrations of counter-regulatory hormones mark-
edly increase in response to stress in conditions such as 
sepsis or trauma)7-9. Th e mortality rate from DKA in 
children is 0.15%-0.30% and the major cause that ac-
counts for 60%-90% of all DKA deaths is cerebral 
edema8. Among other causes of mortality and morbid-
ity, ARDS also presents a predictor of high mortality 
but this entity is rarely encountered in pediatric popu-
lation8,10,11. Th e true mechanism of ARDS during 
DKA remains unclear. Previously, it was estimated 
that DM patients had an increased capillary permea-
bility12. It can be speculated that severe acidosis as in 
our patient with DKA could cause an increase in the 
permeability of capillary membranes, leading to altera-
tion of the alveolar surfactant metabolism4. However, 
many patients are very acidotic at the onset of DKA 
but only few of them develop ARDS11. Th is supports 
the hypothesis of the multifactorial etiology of ARDS 
as a complication of DKA13.
Fig. 2A, B. Chest high-resolution computed tomography demonstrating bilateral areas of patchy 
abnormalities and mixed ground-glass appearance and consolidation.
Fig. 3. Chest x-ray demonstrating complete clearance 
of diff use infi ltrates.
I. Pavić et al. ARDS and diabetic ketoacidosis
Acta Clin Croat, Vol. 57, No. 3, 2018 591
Th e mainstay of treatment of DKA is insulin ther-
apy, rehydration with large quantities of intravenous 
crystalloid fl uids, and replacement of electrolyte defi -
cits9. It was shown that overly vigorous hydration 
raised the risk of ARDS possibly by increasing hydro-
static pressure and decreasing intravascular oncotic 
pressure7. Th ese alterations of the hydrostatic-oncotic 
forces make the patients with DKA prone to develop-
ing pulmonary edema. However, although most pa-
tients receive large volumes of fl uids, ARDS is an in-
frequent complication2.
Hoff man et al.14 showed that metabolic changes in 
DKA and its treatment had diff erential eff ects on cel-
lular activation and cytokine release. A signifi cant de-
crease in interleukin (IL)-10 as a known anti-infl am-
matory cytokine and increases in IL-1beta, IL-8 and 
tumor necrosis factors (TNF)-alfa as proinfl ammatory 
cytokines were observed. Th ey also noted that the pro-
gression of interstitial pulmonary edema correlated 
with the time frame of infl ammatory cytokine en-
hancement, supporting their role in diff use infl amma-
tory lung injury defi ning ARDS14.
It is not clear why only a minority of patients with 
known exposure to risk factors develop ARDS. It 
seems that genetic predisposition in combination with 
severe acidosis, alteration in hydrostatic-oncotic forces 
due to large volumes of crystalloid fl uids and proin-
fl ammatory cytokine enhancement can lead to ARDS 
in a patient with DKA. A number of gene polymor-
phisms associated with the susceptibility to ARDS 
have been discovered, i.e. angiotensin converting en-
zyme gene, pulmonary surfactant-associated protein 
B, IL-6, angiopoietin-2 and coagulation factor V14-17. 
Th ere is hope that these studies may help recognize 
patients at a greater risk of ARDS early and initiate 
development of better treatment based on personal-
ized therapy that could improve survival. For now, the 
mainstay of treatment for ARDS is aggressive man-
agement of the underlying cause, mechanical ventila-
tion and high fl ow oxygen therapy. Survival without 
sequels is increased with improved management. We 
therefore suggest that any suspicion of the develop-
ment of ARDS syndrome, sudden onset of dyspnea, 
progressive hypoxemia accompanied by development 
of diff use infi ltrates on chest x-ray in a child with 
DKA warrants high level of concern and intensive care 
monitoring.
In conclusion, to improve survival of patients with 
ARDS as a complication of DKA, physicians should 
be aware of this rare pulmonary complication and its 
appropriate management.
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Sažetak
SINDROM AKUTNOG RESPIRACIJSKOG DISTRESA U ČETVOROGODIŠNJEG DJEČAKA 
S DIJABETIČNOM KETOACIDOZOM – PRIKAZ SLUČAJA
I. Pavić, D. Tješić Drinković, S. Galić, D. Tješić Drinković i N. Rojnić Putarek
Među poznatim inicijatorima sindroma akutnog respiracijskog distresa (ARDS) dijabetična ketoacidoza (DKA) je naj-
rjeđi. U ovom radu prikazujemo 4-godišnjeg dječaka s DKA kao prvom manifestacijom o inzulinu ovisne šećerne bolesti u 
kojega se razvio ARDS te je zahtijevao mehaničku ventilaciju i preživio bez značajnijih posljedica. Kako bi se unaprijedilo 
preživljenje bolesnika s ARDS kao komplikacijom DKA liječnici trebaju biti upoznati s ovom rijetkom plućnom komplika-
cijom i njezinim pravilnim liječenjem.
Ključne riječi: Dijete; Dijabetična ketoacidoza; Dijabetes melitus, tip 1; Sindrom respiracijskog distresa, odrasla osoba
